BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Daitch V, Yelin D, Awwad M, Guaraldi G, Milić J, Mussini C, Falcone M, Tiseo G, Carrozzi L, Pistelli F, Nehme M, Guessous I, Kaiser L, Vetter P, Bordas-Martínez J, Durà-Miralles X, Peleato-Catalan D, Gudiol C, Shapira-Lichter I, Abecasis D, Leibovici L, Yahav D, Margalit I; ESCMID study group for infections in the elderly (ESGIE). Characteristics of long-COVID among older adults: a cross-sectional study. Int J Infect Dis 2022;125:287-93. [PMID: 36191820 DOI: 10.1016/j.ijid.2022.09.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Conti V, Corbi G, Sabbatino F, De Pascale D, Sellitto C, Stefanelli B, Bertini N, De Simone M, Liguori L, Di Paola I, De Bernardo M, Tesse A, Rosa N, Pagliano P, Filippelli A. Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches. J Pers Med 2023;13. [PMID: 36836568 DOI: 10.3390/jpm13020334] [Reference Citation Analysis]
2 Patel M, Uthman O. Risk factors for newly-developed cardiovascular disease and quality of life during the COVID -19 pandemic: an analysis of the English Longitudinal Study of Ageing.. [DOI: 10.21203/rs.3.rs-2538008/v1] [Reference Citation Analysis]
3 Romero-Rodríguez E, Perula-de-Torres LÁ, González-Lama J, Castro-Jiménez RÁ, Jiménez-García C, Priego-Pérez C, Vélez-Santamaría R, Simón-Vicente L, González-Santos J, González-Bernal JJ. Long COVID Symptomatology and Associated Factors in Primary Care Patients: The EPICOVID-AP21 Study. Healthcare (Basel) 2023;11. [PMID: 36673587 DOI: 10.3390/healthcare11020218] [Reference Citation Analysis]
4 Haque A, Pant AB. Long Covid: Untangling the Complex Syndrome and the Search for Therapeutics. Viruses 2022;15. [PMID: 36680082 DOI: 10.3390/v15010042] [Reference Citation Analysis]
5 Cimellaro A, Addesi D, Cavallo M, Spagnolo F, Suraci E, Cordaro R, Spinelli I, Passafaro F, Colosimo M, Pintaudi M, Pintaudi C, On Behalf Of The CATAnzaro LOng Covid Cataloco Study Group. Monoclonal Antibodies and Antivirals against SARS-CoV-2 Reduce the Risk of Long COVID: A Retrospective Propensity Score-Matched Case-Control Study. Biomedicines 2022;10. [PMID: 36551891 DOI: 10.3390/biomedicines10123135] [Reference Citation Analysis]